Udg Healthcare PLC (LON:UDG) has been given a consensus recommendation of “Hold” by the nine research firms that are presently covering the company, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is GBX 781.57 ($9.94).

A number of analysts have recently weighed in on UDG shares. Berenberg Bank boosted their target price on shares of Udg Healthcare PLC from GBX 745 ($9.48) to GBX 800 ($10.18) and gave the stock a “hold” rating in a report on Friday, June 23rd. Liberum Capital restated a “buy” rating and issued a GBX 930 ($11.83) target price on shares of Udg Healthcare PLC in a report on Monday, June 19th. Jefferies Group LLC downgraded shares of Udg Healthcare PLC to a “hold” rating and boosted their target price for the stock from GBX 760 ($9.67) to GBX 785 ($9.98) in a report on Wednesday, May 24th. Peel Hunt lifted their price target on shares of Udg Healthcare PLC from GBX 730 ($9.29) to GBX 830 ($10.56) and gave the stock an “add” rating in a research note on Tuesday, May 23rd. Finally, Numis Securities Ltd reaffirmed a “hold” rating and set a GBX 730 ($9.29) price target on shares of Udg Healthcare PLC in a research note on Tuesday, May 23rd.

Shares of Udg Healthcare PLC (LON UDG) opened at 864.50 on Friday. The firm’s 50-day moving average is GBX 811.32 and its 200 day moving average is GBX 721.72. The stock’s market capitalization is GBX 2.14 billion. Udg Healthcare PLC has a 52-week low of GBX 518.50 and a 52-week high of GBX 871.00.

The business also recently declared a dividend, which was paid on Tuesday, June 27th. Shareholders of record on Thursday, June 1st were given a dividend of $0.04 per share. This represents a dividend yield of 0.35%. The ex-dividend date was Thursday, June 1st.

In other news, insider Chris Corbin sold 100,000 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of GBX 813 ($10.34), for a total value of £813,000 ($1,034,088.02). Also, insider Jez Moulding acquired 18,000 shares of the stock in a transaction dated Wednesday, May 31st. The stock was acquired at an average cost of GBX 808 ($10.28) per share, with a total value of £145,440 ($184,991.10).

ILLEGAL ACTIVITY WARNING: “Udg Healthcare PLC (UDG) Given Average Recommendation of “Hold” by Analysts” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/06/30/udg-healthcare-plc-udg-given-average-recommendation-of-hold-by-analysts.html.

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.